Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder

Human Pathology

Volumn 45, Issue 7, 2014, Pages 1473-1482

  Paner, Gladell P ^a   Annaiah, Chandrakanth ^b   Gulmann, Christian ^b,c   Rao, Priya ^d   Ro, Jae Y ^e   Hansel, Donna E ^f   Shen, Steven S ^e   Lopez Beltran, Antonio ^g   Aron, Manju ^b   Luthringer, Daniel J ^b   De Peralta Venturina, Mariza ^b   Cho, Yong ^h   Amin, Mahul B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c BEAUMONT HOSPITAL   (Ireland)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CÓRDOBA   (Spain)

^h University of Ulsan College of Medicine   (South Korea)

Author keywords

GATA3; Immunohistochemistry; S 100P; Undifferentiated; Urothelial; Variant

Indexed keywords

CYTOKERATIN; CYTOKERATIN 7; PROTEIN P63; PROTEIN S 100; THROMBOMODULIN; TRANSCRIPTION FACTOR GATA 3; UROPLAKIN 3;

BLADDER CARCINOMA; CARCINOMA; CELL DIFFERENTIATION; CLEAR CELL CARCINOMA; CONFERENCE PAPER; GIANT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROCYSTIS AERUGINOSA; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; RHABDOID TUMOR; SARCOMATOID CARCINOMA; SMALL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

GATA3; IMMUNOHISTOCHEMISTRY; S-100P; UNDIFFERENTIATED; UROTHELIAL; VARIANT;

CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84903172525     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.02.024     Document Type: Conference Paper

References (56)

1. M.B. Amin, J.K. McKenney, and G.P. Paner et al. ICUD-EAU International Consultation on Bladder Cancer 2012: pathology Eur Urol 63 2013 16 35
2. S.L. Johansson, G. Borghede, and S. Holmang Micropapillary bladder carcinoma: a clinicopathological study of 20 cases J Urol 161 1999 1798 1802 (Pubitemid 29420734)
3. A. Lopez-Beltran, R. Montironi, A. Blanca, and L. Cheng Invasive micropapillary urothelial carcinoma of the bladder Hum Pathol 41 2010 1159 1164
4. T.L. Lotan, H. Ye, J. Melamed, X.R. Wu, M. Shih Ie, and J.I. Epstein Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma Am J Surg Path 33 2009 1037 1041
5. H. Samaratunga, and K. Khoo Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study Histopathology 45 2004 55 64 (Pubitemid 38969562)
6. R. Yamashita, R. Yamaguchi, K. Yuen, M. Niwakawa, and K. Tobisu Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stain Int J Urol 13 2006 1448 1450 (Pubitemid 44657058)
7. M. Rotellini, C. Fondi, M. Paglierani, N. Stomaci, and M.R. Raspollini Clear cell carcinoma of the bladder in a patient with a earlier clear cell renal cell carcinoma: a case report with morphologic, immunohistochemical, and cytogenetical analysis Appl Immunohistochem Mol Morphol 18 2010 396 399
8. M.W. Kramer, M. Abbas, and S. Pertschy et al. Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature Rare tumors 4 2012 e48
9. M.J. Wasco, S. Daignault, D. Bradley, and R.B. Shah Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases Hum Pathol 41 2010 163 171
10. A. Lopez-Beltran, M.J. Requena, R. Montironi, A. Blanca, and L. Cheng Plasmacytoid urothelial carcinoma of the bladder Hum Pathol 40 2009 1023 1028
11. P. Nigwekar, P. Tamboli, M.B. Amin, A.O. Osunkoya, D. Ben-Dor, and M.B. Amin Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases Am J Surg Pathol 33 2009 417 424
12. M.R. Raspollini, I. Sardi, and L. Giunti et al. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series Hum Pathol 42 2011 1149 1158
13. J.Y. Ro, S.S. Shen, and H.I. Lee et al. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases Am J Surg Pathol 32 2008 752 757 (Pubitemid 351600823)
14. D. Kozyrakis, C. Petraki, I. Prombonas, A. Grigorakis, G. Kanellis, and D. Malovrouvas Lymphoepithelioma-like bladder cancer: clinicopathologic study of six cases Int J Urol 18 2011 731 734
15. S.R. Williamson, S. Zhang, and A. Lopez-Beltran et al. Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features Am J Surg Pathol 35 2011 474 483
16. L. Cheng, C.X. Pan, and X.J. Yang et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients Cancer 101 2004 957 962 (Pubitemid 39100428)
17. S.E. Mills, J.T. Wolfe 3rd, and M.A. Weiss et al. Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases Am J Surg Pathol 11 1987 606 617 (Pubitemid 17128979)
18. L. Cheng, S. Zhang, and R. Alexander et al. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation Am J Surg Pathol 35 2011 e34 e46
19. N.H. Bassily, C.J. Vallorosi, G. Akdas, J.E. Montie, and M.A. Rubin Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma Am J Clin Pathol 113 2000 383 388 (Pubitemid 30217386)
20. P.G. Chu, and L.M. Weiss Keratin expression in human tissues and neoplasms Histopathology 40 2002 403 439 (Pubitemid 34535443)
21. A.Y. Chuang, A.M. DeMarzo, R.W. Veltri, R.B. Sharma, C.J. Bieberich, and J.I. Epstein Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma Am J Surg Pathol 31 2007 1246 1255 (Pubitemid 47207130)
22. E. Comperat, P. Camparo, and R. Haus et al. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases Virchows Arch 448 2006 319 324 (Pubitemid 43361886)
23. N.T. Gaisa, T. Braunschweig, and N. Reimer et al. Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer Virchows Arch 458 2011 301 312
24. P. Harnden, and J. Southgate Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas J Clin Pathol 50 1997 1032 1033 (Pubitemid 28055633)
25. T. Hayashi, K. Sentani, and N. Oue et al. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma Histopathology 59 2011 710 721
26. J.P. Higgins, G. Kaygusuz, and L. Wang et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680 (Pubitemid 46684205)
27. H.Y. Huang, S.F. Shariat, and T.T. Sun et al. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome Hum Pathol 38 2007 1703 1713 (Pubitemid 47589094)
28. O. Kaufmann, E. Fietze, J. Mengs, and M. Dietel Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas Am J Clin Pathol 116 2001 823 830 (Pubitemid 33108152)
29. N. Kuroda, M. Tamura, M. Ohara, T. Hirouchi, K. Mizuno, and E. Miyazaki Invasive micropapillary carcinoma of the urinary bladder: an immunohistochemical study of neoplastic and stromal cells Int J Urol 13 2006 1015 1018 (Pubitemid 44049942)
30. L.P. Kunju, R. Mehra, M. Snyder, and R.B. Shah Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma Am J Clin Pathol 125 2006 675 681
31. R. Moll, X.R. Wu, J.H. Lin, and T.T. Sun Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas Am J Pathol 147 1995 1383 1397
32. D.C. Parker, A.L. Folpe, and J. Bell et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas Am J Surg Pathol 27 2003 1 10 (Pubitemid 36014893)
33. M. Srinivasan, and A.V. Parwani Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma Diagn Pathol 6 2011 67
34. M. Varma, M. Morgan, M.B. Amin, S. Wozniak, and B. Jasani High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer Histopathology 42 2003 167 172 (Pubitemid 36237849)
35. A.M. Gruver, M.B. Amin, and D.J. Luthringer et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung Arch Pathol Lab Med 136 2012 1339 1346
36. A. Chang, A. Amin, and E. Gabrielson et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung Am J Surg Pathol 36 2012 1472 1476
37. C. Gulmann, G.P. Paner, and R.S. Parakh et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract Hum Pathol 44 2013 164 172
38. H. Liu, J. Shi, M.L. Wilkerson, and F. Lin Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas Am J Clin Pathol 138 2012 57 64
39. M. Miettinen, P.A. McCue, and M. Sarlomo-Rikala et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors Am J Surg Pathol 38 2014 13 22
40. L. Zhao, T. Antic, and D. Witten et al. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas Am J Surg Pathol 37 2013 1876 1881
41. J. Jiang, T.M. Ulbright, and C. Younger et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis Arch Pathol Lab Med 125 2001 921 923 (Pubitemid 32623190)
42. O. Kaufmann, J. Volmerig, and M. Dietel Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas Am J Clin Pathol 113 2000 683 687 (Pubitemid 33044309)
43. G.E. Esheba, T.A. Longacre, K.A. Atkins, and J.P. Higgins Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations Am J Surg Pathol 33 2009 347 353
44. J.S. Lewis, J.H. Ritter, and S. El-Mofty Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1 Mod Pathol 18 2005 1471 1481 (Pubitemid 41509402)
45. Q. Rao, S.R. Williamson, and A. Lopez-Beltran et al. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers Mod Pathol 26 2013 725 732
46. A. Sari, M.A. Uyaroglu, M. Ermete, M. Oder, C. Girgin, and C. Dincer Microcystic urothelial carcinoma of the urinary bladder metastatic to the penis Pathol Oncol Res 13 2007 170 173 (Pubitemid 47204743)
47. H.M. Fritsche, M. Burger, S. Denzinger, W. Legal, P.J. Goebell, and A. Hartmann Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases J Urol 180 2008 1923 1927
48. N. Buza, P.J. Cohen, H. Pei, and V. Parkash Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder Int J Surg Pathol 18 2010 94 102
49. M.J. Fernandez-Acenero, S. Cordova, F. Manzarbeitia, and C. Medina Immunohistochemical profile of urothelial and small cell carcinomas of the bladder Pathol Oncol Res 17 2011 519 523
50. T.D. Jones, K.M. Kernek, and X.J. Yang et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases Hum Pathol 36 2005 718 723 (Pubitemid 41112025)
51. N.G. Ordonez Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas Am J Surg Pathol 24 2000 1217 1223
52. P. Soriano, S. Navarro, M. Gil, and A. Llombart-Bosch small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases Virchows Arch 445 2004 292 297 (Pubitemid 39286898)
53. S. Thompson, M. Cioffi-Lavina, J. Chapman-Fredricks, C. Gomez-Fernandez, G. Fernandez-Castro, and M. Jorda Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach Appl Immunohistochem Mol Morphol 19 2011 395 399
54. D.E. Westfall, A.L. Folpe, and G.P. Paner et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder Am J Surg Pathol 33 2009 99 105
55. H. Ikegami, H. Iwasaki, Y. Ohjimi, T. Takeuchi, A. Ariyoshi, and M. Kikuchi Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients Hum Pathol 31 2000 332 340 (Pubitemid 30161352)
56. J.S. So, and J.I. Epstein GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma Mod Pathol 26 2013 1365 1370